DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Investigation of Efficiency of Breathing With Different Breathing Patterns

Not Applicable

Completed

Conditions: Respiratory Insufficiency
Respiratory Physiology
Breathing Patterns

Interventions: Other: Breathing Patterns

First Posted Date: 2008-11-02

Last Posted Date: 2014-12-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 26

Registration Number: NCT00784004

Locations: 🇺🇸
Massachusetts General Hospital, Respiratory Care Laboratory, Boston, Massachusetts, United States

The Feasibility and Accuracy of Exhaled CO2 to Measure Cardiac Output in Ventilated Patients Without Tracheal Intubation

Not Applicable

Withdrawn

Conditions: Cardiac Physiology
Cardiac Output

Interventions: Device: NICO device

First Posted Date: 2008-11-02

Last Posted Date: 2012-04-25

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT00783679

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation

Not Applicable

Terminated

Conditions: Mixed Venous Oxygen Saturation
Tissue Oxygenation

Interventions: Device: Cerebral/Somatic Tissue Oximeter device
Device: Pulmonary artery catheter

First Posted Date: 2008-11-02

Last Posted Date: 2017-04-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 8

Registration Number: NCT00783952

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy

Terminated

Conditions: Vitiligo
Melasma
Hyperpigmentation
Hypopigmentation

First Posted Date: 2008-10-13

Last Posted Date: 2011-03-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT00771355

Locations: 🇺🇸
Clinical Unit for Research Trials in Skin, Boston, Massachusetts, United States

The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa

Phase 2

Completed

Conditions: Anorexia Nervosa
Osteoporosis

Interventions: Drug: Placebo
Drug: Teriparatide

First Posted Date: 2008-09-25

Last Posted Date: 2017-05-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT00759772

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma

Not Applicable

Terminated

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: temozolomide
Other: Imaging biomarker analysis
Radiation: Photon Radiation Therapy

First Posted Date: 2008-09-19

Last Posted Date: 2020-05-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 15

Registration Number: NCT00756106

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Clinical Management of Neuropathic Pain With Ramelteon

Not Applicable

Terminated

Conditions: Neuropathic Pain

Interventions: Drug: Ramelteon
Drug: Placebo

First Posted Date: 2008-09-16

Last Posted Date: 2017-05-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT00753623

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults

Phase 4

Completed

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)

Interventions: Drug: Lisdexamfetamine

First Posted Date: 2008-09-16

Last Posted Date: 2012-09-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 24

Registration Number: NCT00753012

Locations: 🇺🇸
Massachusetts General Hospital, Cambridge, Massachusetts, United States

Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia

Interventions: Drug: D-cycloserine
Behavioral: Cognitive Behavioral Therapy

First Posted Date: 2008-08-27

Last Posted Date: 2017-12-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 21

Registration Number: NCT00742079

Locations: 🇺🇸
MGH Schizophrenia Program - Freedom Trail Clinic, Boston, Massachusetts, United States

hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects

Not Applicable

Completed

Conditions: Healthy Subjects
Vitamin D Deficiency

Interventions: Drug: ergocalciferol

First Posted Date: 2008-08-27

Last Posted Date: 2016-04-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 99

Registration Number: NCT00742235

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy